Ranitidine (INN) (IPA: ) is a histamine H2-receptor antagonist that inhibits stomach acid production, and commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). It is currently marketed by GlaxoSmithKline under the trade name Zantac.
Certain preparations of ranitidine are available over the counter (OTC) in various countries. In the United States, 75 mg and 150 mg tablets are available OTC. In Australia, small packs of 150 mg and 300 mg tablets are Schedule 2 Pharmacy Medicines. Larger doses and pack sizes still require a prescription.
More on [ Ranitidine ]

DrugDigest: Ranitidine ( Zantac ) - Information on dosage, usage, side effects, interactions, and drug comparisons, including generics when available.
Tritec - Ranitidine bismuth citrate. Product information for US residents in PDF format. [Acrobat Reader required]
Meta Description: [ This site serves as the homepage of GSK's corporate web site. ]
404
Zantac - Product information for US residents in PDF format. [Acrobat Reader required]
Meta Description: [ About GSK summarizes the mission of GSK and provides users with an overview of the organization and biographies of our Board of Directors and Corporate Executive Team. ]
Zantac75.com - A dynamic gathering place where medical professionals can obtain information about heartburn and digestive health.
Meta Description: [ Intermittent heartburn relief, e-detailing, patient tools, healthcare professionals - Zantac 75® Web site for doctors, physicians and healthcare professionals. ]
| Why I Take Prevacid (A "Big" Acid Reflux Medication) | |